Cyclosporin A
Cyclosporin A is a pharmaceutical drug with 28 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
7
Mid Stage
13
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.7%
13 of 15 finished
13.3%
2 ended early
2
trials recruiting
28
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)
Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA
Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response
A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.
Clinical Trials (28)
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)
Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA
Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response
A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.
Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
Outcomes of Patients After Allo-HSCT With Decitabine and NAC
Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy
Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia
Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome
Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy
Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema
Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)
Stem Cell Transplant for Immunologic or Histiocytic Disorders
Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant
Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant
12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients
A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP)
Use of Cyclosporin A for the Treatment of Recurrent Miscarriage
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 28